Glucocorticoid use, other associated factors, and the risk of tuberculosis

Arthritis Care and Research

Volumn 55, Issue 1, 2006, Pages 19-26

  Jick, Susan S ^a   Lieberman, Eric S ^b,c   Rahman, Mahboob U ^d   Choi, Hyon K ^b,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Summit Medical Group   (United States)

^d CENTOCOR INC   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adiposity; Bronchitis; Emphysema; Glucocorticoid; Smoking; Tuberculosis

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GLUCOCORTICOID; GOLD; HYDROCORTISONE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BODY MASS; BRONCHITIS; CASE CONTROL STUDY; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; EMPHYSEMA; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OBESITY; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; TUBERCULOSIS; UNITED KINGDOM;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHEUMATIC DISEASES; RISK FACTORS; SMOKING; TUBERCULOSIS, PULMONARY;

EID: 32544459126     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21705     Document Type: Article

References (23)

1. Wallis RS, Johnson JL. Adult tuberculosis in the 21st century: pathogenesis, clinical features, and management. Curr Opin Pulm Med 2001;7:124-32.
2. Jaramillo E. DOTS-Plus and the Green Light Committee. Presented at "Meet the Expert" session of the 33rd IUATLD World Conference on Lung Health; Montreal, Quebec, Canada; 2002.
3. Targeted tuberculin testing and treatment of latent tuberculosis infection: joint statement of the American Thoracic Society and the Centers for Disease Control and Prevention. Am J Respir Crit Care Med 2000;161:S221-47.
4. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
5. Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al, and the EMECAR Study Group. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003;30:1436-9.
6. Gomez-Reino JJ, Carmona L, Valverde VR, MoIa EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
7. Schatz M, Patterson R, Kloner R, Falk J. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med 1976;84:261-5.
8. Bovornkitti S, Kangsadal P, Sathirapat P, Oonsombatti P. Reversion and reconversion rate of tuberculin skin reactions in correction with the use of prednisone. Dis Chest 1960;38:51-5.
9. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS, et al. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 1998;16:9-13.
10. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, et al. Validity of the general practice research database. Pharmacotherapy 2003;23:686-9.
11. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
12. Bradford Hill A. The environment and disease: association of causation. Proc Royal Soc Med 1965;58:295-300.
13. Rose AM, Watson JM, Graham C, Nunn AJ, Drobniewski F, Ormerod LP, et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 2001;56:173-9.
14. Centers for Disease Control and Prevention. URL: http:// www.cdc.gov/nchstp/tb/surv/surv2003.
15. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9.
16. Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481-97.
17. Balow JE, Rosenthal AS. Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med 1973;137:1031-41.
18. Rinehart JJ, Sagone AL, Balcerzak SP, Ackerman GA, LoBuglio AF. Effects of corticosteroid therapy on human monocyte function. N Engl J Med 1975;292:236-41.
19. Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997;23:219-37.
20. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304-15.
21. Palmer CE, Jablon S, Edwards PQ. Tuberculosis morbidity of young men in relation to tuberculin sensitivity and body build. Am Rev Tuberc 1957;76:517-39.
22. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003;362:507-15.
23. Boelaert JR, Gomes MS, Gordeuk VR. Smoking, iron, and tuberculosis. Lancet 2003;362:1243-4.